Search Results - "RIBOLDAZZI, Giulio"

Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients by Kustrimovic, Natasa, Comi, Cristoforo, Magistrelli, Luca, Rasini, Emanuela, Legnaro, Massimiliano, Bombelli, Raffaella, Aleksic, Iva, Blandini, Fabio, Minafra, Brigida, Riboldazzi, Giulio, Sturchio, Andrea, Mauri, Marco, Bono, Giorgio, Marino, Franca, Cosentino, Marco

“…Parkinson's disease (PD) affects an estimated 7 to 10 million people worldwide, and only symptomatic treatments are presently available to relieve the…”
Get full text

Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study by Zangaglia, Roberta, Martignoni, Emilia, Glorioso, Margaret, Ossola, Maria, Riboldazzi, Giulio, Calandrella, Daniela, Brunetti, Gabriele, Pacchetti, Claudio

“…Chronic constipation is the most frequent symptom of autonomic system involvement in Parkinson's disease (PD). Quite often the symptom is severe and impairs…”
Get full text

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease by Comi, Cristoforo, Ferrari, Marco, Marino, Franca, Magistrelli, Luca, Cantello, Roberto, Riboldazzi, Giulio, Bianchi, Maria Laura Ester, Bono, Giorgio, Cosentino, Marco

“…L-dopa-induced dyskinesia (LID) is a frequent motor complication of Parkinson's disease (PD), associated with a negative prognosis. Previous studies showed an…”
Get full text

Selegiline reduces daytime sleepiness in patients with Parkinson's disease by Gallazzi, Marco, Mauri, Marco, Bianchi, Maria Laura, Riboldazzi, Giulio, Princiotta Cariddi, Lucia, Carimati, Federico, Rebecchi, Valentina, Versino, Maurizio

“…Objectives Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs…”
Get full text

The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients by Antonini, Angelo, Abbruzzese, Giovanni, Berardelli, Alfredo, Modugno, Nicola, Stroppa, Italo, Tamma, Filippo, Sensi, Mariachiara, Mancini, Francesca, Cossu, Giovanni, Stefani, Alessandro, Tambasco, Nicola, Tessitore, Alessandro, Fabbrini, Giovanni, Pontieri, Francesco E., Solla, Paolo, Bentivoglio, Anna Rita, Comi, Cristoforo, Minafra, Brigida, Riboldazzi, Giulio, Melchionda, Donato, Martino, Tommaso, Lopiano, Leonardo

“…The TANDEM investigation was carried out in 17 Italian Movement Disorder centers on behalf of a joint initiative of neurologist members of the Italian Academy…”
Get full text

Design and Operation of the Lombardy Parkinson's Disease Network by Albanese, Alberto, Di Fonzo, Alessio, Fetoni, Vincenza, Franzini, Angelo, Gennuso, Michele, Molini, Graziella, Pacchetti, Claudio, Priori, Alberto, Riboldazzi, Giulio, Volonté, Maria Antonietta, Calandrella, Daniela

“…Background: Parkinson's disease (PD) is one of the most common chronic neurological conditions leading to disability and social burden. According to the 2016…”
Get full text

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson's Disease by Corrado, Lucia, De Marchi, Fabiola, Tunesi, Sara, Oggioni, Gaia Donata, Carecchio, Miryam, Magistrelli, Luca, Tesei, Silvana, Riboldazzi, Giulio, Di Fonzo, Alessio, Locci, Clarissa, Trezzi, Ilaria, Zangaglia, Roberta, Cereda, Cristina, D'Alfonso, Sandra, Magnani, Corrado, Comi, Giacomo P, Bono, Giorgio, Pacchetti, Claudio, Cantello, Roberto, Goldwurm, Stefano, Comi, Cristoforo

“…Alpha-synuclein is a constituent of Lewy bodies and mutations of its gene cause familial Parkinson's disease (PD). A previous study showed that a variant of…”
Get full text

Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs by Mauri, Marco, Corbetta, Simona, Pianezzola, Cristina, Ambrosoni, Elena, Riboldazzi, Giulio, Bono, Giorgio

“…Mild parkinsonian signs (MPS) may be found among patients presenting with mild cognitive impairment (MCI), but few data are available about the relation of…”
Get full text

Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease by Bianchi, Maria Laura Ester, Riboldazzi, Giulio, Mauri, Marco, Versino, Maurizio

“…The primary endpoint of this work was to evaluate the effect of safinamide on non-motor symptoms (NMS) in patients affected by idiopathic Parkinson’s disease…”
Get full text

Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy by Cosentino, Marco, Martignoni, Emilia, Michielotto, Donatella, Calandrella, Daniela, Riboldazzi, Giulio, Pacchetti, Claudio, Frigo, Gianmario, Nappi, Giuseppe, Lecchini, Sergio

“…Parkinson's disease (PD) is a chronic neurodegenerative disease which at present has no cure, and it usually results in severe disability. The burden of PD…”
Get full text

Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients by Leoni, Olivia, Martignoni, Emilia, Cosentino, Marco, Michielotto, Donatella, Calandrella, Daniela, Zangaglia, Roberta, Riboldazzi, Giulio, Oria, Cristina, Lecchini, Sergio, Nappi, Giuseppe, Frigo, Gianmario

“…Purpose Drug treatment of idiopathic Parkinson's disease (IPD) is a difficult task, and comorbidity and comedication add to its complexity. Since in IPD there…”
Get full text

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease by Kustrimovic, Natasa, Rasini, Emanuela, Legnaro, Massimiliano, Bombelli, Raffaella, Aleksic, Iva, Blandini, Fabio, Comi, Cristoforo, Mauri, Marco, Minafra, Brigida, Riboldazzi, Giulio, Sanchez-Guajardo, Vanesa, Marino, Franca, Cosentino, Marco

“…Parkinson’s disease (PD) is characterized by loss of dopaminergic neurons in substantia nigra pars compacta, α-synuclein (α-syn)-rich intraneuronal inclusions…”
Get full text

Intensive Rehabilitation Treatment in Early Parkinson’s Disease: A Randomized Pilot Study With a 2-Year Follow-up by Frazzitta, Giuseppe, Maestri, Roberto, Bertotti, Gabriella, Riboldazzi, Giulio, Boveri, Natalia, Perini, Michele, Uccellini, Davide, Turla, Marinella, Comi, Cristoforo, Pezzoli, Gianni, Ghilardi, M. Felice

“…Background. Although physical exercise improves motor aspects of Parkinson’s disease (PD), it is not clear whether it may also have a neuroprotective effect…”
Get full text

Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome by Barichella, Michela, Cereda, Emanuele, Pinelli, Giovanna, Iorio, Laura, Caroli, Diana, Masiero, Irene, Ferri, Valentina, Cassani, Erica, Bolliri, Carlotta, Caronni, Serena, Maggio, Marcello, Ortelli, Paola, Ferrazzoli, Davide, Maras, Antonios, Riboldazzi, Giulio, Frazzitta, Giuseppe, Pezzoli, Gianni

“…OBJECTIVEWe evaluated the efficacy of muscle-targeted nutritional support on the functional outcomes of multidisciplinary intensive rehabilitation treatment…”
Get full text

Intensive Rehabilitation Increases BDNF Serum Levels in Parkinsonian Patients: A Randomized Study by Frazzitta, Giuseppe, Maestri, Roberto, Ghilardi, Maria Felice, Riboldazzi, Giulio, Perini, Michele, Bertotti, Gabriella, Boveri, Natalia, Buttini, Sara, Lombino, Franco Luis, Uccellini, Davide, Turla, Marinella, Pezzoli, Gianni, Comi, Cristoforo

“…Background. Exercise may decrease the risk of Parkinson’s disease (PD) in humans and reduce PD symptoms in animal models. The beneficial effects have been…”
Get full text

Correction to: Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease by Bianchi, Maria Laura Ester, Riboldazzi, Giulio, Mauri, Marco, Versino, Maurizio

“…The original version of this article contains an error in Table 2. The Authors realized that they submitted the previous version of Table 2. The correct…”
Get full text

Effectiveness of expiratory flow acceleration in patients with Parkinson's disease and swallowing deficiency: A preliminary study by Riboldazzi, Giulio, Spinazza, Giada, Beccarelli, Laura, Prato, Paola, Grecchi, Bruna, D’Abrosca, Francesco, Nicolini, Antonello

“…•Parkinson's disease (PD) can cause dysfunction both to swallowing and to the cough mechanism. Oropharyngeal dysphagia is the main cause of pneumonia due to…”
Get full text

Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients: A Randomized Controlled Trial With 1-Year Follow-up by Frazzitta, Giuseppe, Bertotti, Gabriella, Riboldazzi, Giulio, Turla, Marinella, Uccellini, Davide, Boveri, Natalia, Guaglio, Gabriele, Perini, Michele, Comi, Cristoforo, Balbi, Pietro, Maestri, Roberto

“…Background. Rehabilitation treatments have acute beneficial effects in Parkinson’s disease (PD) patients, but whether the effects persist over time is unclear…”
Get full text

The VDR FokI (rs2228570) polymorphism is involved in Parkinson's disease by Agliardi, Cristina, Guerini, Franca Rosa, Zanzottera, Milena, Bolognesi, Elisabetta, Meloni, Mario, Riboldazzi, Giulio, Zangaglia, Roberta, Sturchio, Andrea, Casali, Carlo, Di Lorenzo, Cherubino, Minafra, Brigida, Clerici, Mario

“…The etiology of Parkinson's disease (PD) is presumably multifactorial and likely involves interactions between genetic and environmental factors, as well as…”
Get full text

TNF-α −308 G/A and −238 G/A promoter polymorphisms and sporadic Parkinson's disease in an Italian cohort by Agliardi, Cristina, Guerini, Franca Rosa, Zanzottera, Milena, Riboldazzi, Giulio, Zangaglia, Roberta, Bono, Giorgio, Casali, Carlo, Di Lorenzo, Cherubino, Pacchetti, Claudio, Nemni, Raffaello, Clerici, Mario

“…The etiology of sporadic Parkinson's disease is (PD) still not understood but it is believed that a complex interplay between environmental and genetic factors…”
Get full text